Cwestiwn ysgrifenedig WQ97555

The Welsh Government is committed to improving cancer outcomes and recognises the importance of a strong cancer research base.

Each year, Welsh Government provides the NHS with approximately £18m to fund an extensive Wales-wide research delivery infrastructure – including dedicated healthcare professionals – to support patient participation in clinical trials. The resources required for each study vary. Individual cost breakdowns at study level are not collected.

Since April 2022:

• There have been 378 cancer studies open in Wales, 25% of the 1,539 portfolio studies open during that period.

• There were 81 open studies relating to brain, liver, lung, oesophageal, pancreatic or stomach cancer, 21% of total cancer studies.

Through our direct Health and Care Research funding schemes, £3.94m has been allocated to 14 cancer studies since 2021-22:

Less survivable cancers

Number of awards

Amount of funding

Brain

1

£166k

Lung

1

£230k

Stomach

1

£136k

Other cancers

Blood

1

£66k

Bowel

2

£259k

Breast

2

£604k

Cervical screening

1

£538k

Kidney

1

£453k

Lymphoma

1

£286k

Prostate

1

£600k

Skin

1

£250k

Various - immunotherapy

1

£356k